IL-17A can selectively elevate the expression of chemokines with angiogenic properties by epithelial cells as well as tumor cells, such as CXCL1, CXCL5, CXCL6, and CXCL8 [30, 38]. This evidence concerns the gene CXCL8 and neoplasm.